Undisclosed TSLP inhibitor / Perseus Therap - LARVOL DELTA

Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner (Yahoo Finance) - "Perseus Therapeutics...is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma....TSLP antibodies have recently gained significant attention in the medical and pharmaceutical communities. These antibodies have shown potential in addressing various inflammatory and allergic conditions, driven by their promising efficacy data and the unmet medical needs they aim to fulfill."

New molecule • Asthma • Immunology • Respiratory Diseases